2024 ISPE Biotechnology Conference

Thank you to all who made the 2024 ISPE Biotechnology Conference such a big success!

ISPE - Lisbon 2024
Please Note

All full-access registration (virtual and in-person) includes access to speaker presentations, on-demand content, and other conference material.
NOTE: Material is only available from those speakers/companies that permitted distribution.
Registrants will receive email notification when the on-demand content is available.
On-demand content is accessible for 90 days.

Why attend?

2024 ISPE Biotechnology Conference

Join the forefront of biotechnology innovation at the 2024 ISPE Biotechnology Conference, where industry leaders, technology providers, and top scientists converge to shape the future. This premier event offers unparalleled networking opportunities, cutting-edge insights, and a deep dive into the latest advancements in biosimilars, cell and gene therapy, ATMPs, and mRNA-based products. Don't miss out on expert-led sessions that will drive your process development, speed-to-market strategies, and sustainable manufacturing practices. Be part of the conversation that’s defining the next era of biotechnology.

What to Expect

2024 ISPE Biotechnology Conference: Richard Denk

Attend the 2024 ISPE Biotechnology Conference

Your Conference Experience

Discover the future of biotechnology at the 2024 ISPE Biotechnology Conference.
2024 ISPE Biotechnology Conference
Expo Hall
Expo Hall
Explore groundbreaking innovations and network with industry leaders at our dynamic expo hall.
2024 ISPE Biotechnology Conference
Connect with top industry experts and expand your professional network at our exclusive networking sessions.
2024 ISPE Biotechnology Conference
Live Streams
Live Streams
Experience the conference from anywhere with our interactive live stream.
ISPE - Lisbon 2024
On-Demand Content
On-Demand Content
Access exclusive conference content anytime with our on-demand library for 90 days.

Conference Highlights

Ultragenyx Gene Therapy Facility

Learn the Blank Slate to Building Excellence at the 2024 ISPE Biotechnology Conference

ISPE connected with Sydney Hamilton, Strategic Facility Planner, CRB, and Scott McNallan, Director of Architectural Design, CRB, for a sneak peek look at their planned session, “Blank Slate to Building Excellence,” ahead of the 2024 ISPE Biotechnology Conference. The conference will take place 17-18 June 2024 in Boston, Massachusetts, USA.

Source Aseptic Technologies AT

Trends and Innovations in Bio-Manufacturing. Global Outlook on the Future of Biopharmaceuticals.

The outlook for the biopharmaceutical market is promising, with expectations that the market will double in the next 10 years, resulting in new therapies and advances in biopharmaceutical manufacturing. This doesn't sound like much at first, but if you consider how the market has developed over the last 20 years, a doubling in the next 10 years is very significant.


Data Science-Assisted Biopharmaceutical Tech Transfer and Process Characterization

The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives.

Conference Gallery

Explore Collaborative Advances

Accelerating Biotech Innovation

The 2024 ISPE Biotechnology Conference is a crucial platform for industry leaders, scientists, and regulators to collaborate on the latest advancements in biotechnology.

Enhancing Process Development

Attendees will gain insights into process development enablers, including speed-to-market strategies, sustainable manufacturing practices, and new control strategies.

Exploring Innovative Solutions

This event will explore innovative solutions for cell and gene therapy, ATMPs, and mRNA-based products.

Addressing Challenges and Opportunities

It will address challenges and opportunities in these cutting-edge fields.

International Program Committee

International Board Liaison/Foundation Board Liaison
Vice President, Global Quality Systems and Compliance
Women in Pharma Liaison
Senior Director, Quality Control
Alnylam Pharmaceuticals
International Board Liaison
Senior Director, Global Engineering & Technology
Johnson & Johnson
Operational Excellence Specialist
Thermo Fisher Scientific Brisbane, Australia
Emerging Leader
PhD Candidate
Karlsruhe Institute of Technology (KIT)

Conference Sponsors

Media Partners